Skip to main content
SkinCited

Nicotinamide 用于 紫外线防护(内源性光防护)

A 证据 多项大型临床试验一致显示出显著的益处。

At chemoprevention doses (1,000 mg/day), oral nicotinamide replenishes UV-depleted NAD+ stores, enhancing cellular energy for DNA repair and supporting immune surveillance of UV-damaged cells (ONTRAC Phase 3 trial).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dnicotinamide\u0026condition\u003Duv\u002Dprotection'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

At chemoprevention doses (1,000 mg/day), oral nicotinamide replenishes UV-depleted NAD+ stores, enhancing cellular energy for DNA repair and supporting immune surveillance of UV-damaged cells (ONTRAC Phase 3 trial).

Key Study Findings

Review
The adverse effects of oral niacin/nicotinamide - an overview of reviews.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Overview of reviews on niacin/nicotinamide adverse effects

Meta-Analysis
The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.
Dose: Nicotinamide (vitamin B3) vs: Placebo Outcome: AK and NMSC incidence reduction 效果: None None

研究人群: High-risk NMSC patients (RCTs)

Other
Nicotinamide: An Update and Review of Safety & Differences from Niacin.
Dose: None vs: None Outcome: None 效果: None None

研究人群: None

Review
Final report of the safety assessment of niacinamide and niacin.
Dose: Niacinamide up to 5%; Niacin up to 0.1% vs: None Outcome: Safety assessment for cosmetic use 效果: Safe as used in cosmetics None

研究人群: General population (cosmetic users)

Key Statistics

5

研究数量

686

受试者

Positive

A

等级

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

generalskinbarrier:
500-1,500 mg/day
skincancerchemoprevention:
500 mg twice daily (1,000 mg/day total)

上限: Generally well-tolerated up to 3,000 mg/day (no flushing unlike niacin)

研究中使用的剂量

剂量 持续时间 效果 N
None -- Mixed --
Nicotinamide (vitamin B3) -- Positive --
None -- Mixed --
None -- Mixed --
Niacinamide up to 5%; Niacin up to 0.1% -- Mixed --

最佳服用时间: With meals; split into 2 doses for chemoprevention

Safety & Side Effects

已报告的副作用

  • Generally well-tolerated (no flushing)
  • Mild gastrointestinal discomfort at high doses
  • Rare hepatotoxicity at very high doses

已知相互作用

  • Anticonvulsants (carbamazepine — may increase levels)
  • Isoniazid (competes for NAD+ pathways)
  • Hepatotoxic drugs (potential additive liver effect at high doses)

可耐受最高摄入量: Generally well-tolerated up to 3,000 mg/day (no flushing unlike niacin)

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Nicotinamide help with 紫外线防护(内源性光防护)?
Based on 5 studies with 686 participants, there is strong evidence from multiple clinical trials that Nicotinamide may support 紫外线防护(内源性光防护) management. Our evidence grade is A (Strong Evidence).
How much Nicotinamide should I take for 紫外线防护(内源性光防护)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Nicotinamide?
Reported side effects may include Generally well-tolerated (no flushing), Mild gastrointestinal discomfort at high doses, Rare hepatotoxicity at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Nicotinamide and 紫外线防护(内源性光防护)?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 5 peer-reviewed studies with 686 total participants. The overall direction of effect is positive.

References

  1. [1] Su Ling Young et al.. Eye (Lond). 2025. The adverse effects of oral niacin/nicotinamide - an overview of reviews. doi:10.1038/s41433-025-04027-2 PubMed
  2. [2] Giulio Tosti et al.. Nutrients. 2023. The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis. doi:10.3390/nu16010100 PubMed
  3. [3] Katherine G Thompson et al.. J Am Acad Dermatol. 2021. Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium. doi:10.1016/j.jaad.2020.04.123 PubMed
  4. [4] Reed Huber et al.. Skin Therapy Lett. 2020. Nicotinamide: An Update and Review of Safety & Differences from Niacin. PubMed
  5. [5] Cosmetic Ingredient Review Expert Panel. Int J Toxicol. 2005. Final report of the safety assessment of niacinamide and niacin. doi:10.1080/10915810500434183 PubMed

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。